Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...

A study from St. Jude Children's Research Hospital uncovered an alternative binding pocket within nuclear receptors, ...

An investigational once-weekly amylin receptor agonist conferred substantial weight loss across six different dosing regimens for adults with overweight or obesity, researchers reported in a phase 2 ...

Surprising findings published in PNAS have implications for understanding and treating neurological and neuropsychiatric disorders.

Exclusive collaboration and license agreement focuses on advancing novel T cell therapy “Seed-and-Boost” approach exploiting the mechanism of the ...

Immunocore reports third quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $103.7 million in ...

For decades, scientists believed molecules called leukotrienes were the main culprits behind asthma’s airway-constricting inflammation. But new research suggests that “pseudo leukotrienes” may ...

Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called mu-opioid ...

Scientists at St. Jude Children’s Research Hospital identified a binding cleft in nuclear receptors offering alternative drug ...

Learn how nanobodies from camels and llamas could unlock safer, more precise treatments for Alzheimer’s and schizophrenia.

Hosts David and Gina explore the unexpected origins of blockbuster diabetes and weight-loss drugs like Ozempic and Wegovy ...

Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called mu-opioid ...